Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02628756
Other study ID # MS/490
Secondary ID
Status Completed
Phase N/A
First received December 8, 2015
Last updated December 10, 2015
Start date June 2013
Est. completion date July 2015

Study information

Verified date December 2015
Source Mansoura Integrated Fertility Center
Contact n/a
Is FDA regulated No
Health authority Egypt: Ministry of Higher Education
Study type Interventional

Clinical Trial Summary

Women between 18-39 years old who had been infertile (primary or secondary) for at least 1 year were recruited. In a parallel assignment eligible participants were randomized to receive either a single, site-specific endometrial injury guided by hysteroscopy (Study group) or no intervention (Control group). Natural cycle folliculometry + timed sexual intercourse were offered for all participants for the ongoing and the immediate 2 concecutive cycles. Clinical pregnancy rates were the primary outcome and miscarriage rates were the secondary outcome measures.


Description:

A single site-specific hysteroscopic injury procedure (Snip) will be performed using an office hysteroscopy (Karl Storz, Germany). By means of vaginoscopy, a 2.9 mm. continuous-flow diagnostic hysteroscope with a 5 Fr. working-channel is guided through the cervical canal with normal saline as distension medium, with flow manually regulated through the key of the hysteroscopic sheath.

The examination of the uterine cavity begins by observing its regularity, paying special attention to the presence of intrauterine malformations or morphologic alterations such as submucous myomas, or uterine septa. Subsequently, A claw forceps will be introduced through a 2.2 mm working channel, and will be used to generate a local injury on the upper posterior endometrium (Endometrial Snip) at midline 10-15 mm from the fundus on D4 to D7 of the ongoing menstrual cycle. The depth and width of the injured site will be about 2x2 mm (i.e a single bite of the claw forceps). No premedications, antibiotics or hemostatics will be given after the procedure.

Natural cycle folliculometry + timed sexual intercourse will be offered for all participants for the ongoing and the immediate subsequent cycles. Once the leading ovarian follicle will reach a size of at least 16 mm, 10,000 IU of hCG will be administered to trigger ovulation.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

1. Age between 18 and 39 years old.

2. Normal HSG and/or diagnostic laparoscopy.

3. Normal seminal profile.

4. Regular ovulation confirmed by mid-luteal progesterone.

5. Normal TVS criteria.

Exclusion Criteria:

1. Uterine fibroid.

2. Pelvic endometriosis.

3. Irregular menstruation.

4. Ovarian cysts.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Endometrial injury
Office hysteroscopy (Karl Storz, Tuttlingen, Germany)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mansoura Integrated Fertility Center

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical pregnancy rates (PR) Three consecutive months No
Secondary Miscarriage rates Three consecutive months No
See also
  Status Clinical Trial Phase
Recruiting NCT04169451 - IUI With Letrozole Versus in Natural Cycle N/A
Completed NCT01672801 - Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT N/A
Completed NCT01232465 - Impact of Sperm DNA Integrity on In Vitro Cycles N/A
Not yet recruiting NCT01237535 - Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates Phase 4
Completed NCT02272439 - Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan N/A
Terminated NCT00650754 - Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility Phase 2/Phase 3
Recruiting NCT04754243 - New Protocol in Unexplained Infertility Phase 4
Completed NCT03018314 - Serum Kisspeptin Levels in Infertile Women N/A
Completed NCT02488434 - The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility Phase 3
Completed NCT02739516 - Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility Phase 3
Completed NCT01044862 - Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation Phase 3
Recruiting NCT03386552 - A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility Phase 2
Completed NCT04465045 - Unexplained Infertility Treated by Hysteroscopy-laparoscopy
Completed NCT03461601 - Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility N/A
Completed NCT01859520 - Swim up and Gradient Methods Used in Assisted Reproduction Techniques on DNA Fragmentation of Spermatozoa N/A
Active, not recruiting NCT03828786 - Uterine Scratching in Intra-Uterine Insemination N/A
Completed NCT03397693 - Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.
Withdrawn NCT04955574 - Probiotic and Antibiotic Therapies in Women With Unexplained Infertility Phase 2
Not yet recruiting NCT03398993 - Effect of Endometrial Injury in Couples With Unexplained Infertility N/A
Completed NCT02861105 - The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers Phase 4